Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-11-07

Clinical Trial Update: Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating immediate or deferred pre-exposure prophylaxis for HIV prevention in pregnant and lactating women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of KwaZulu | Conditions: HIV-1-infection | Phase 2, Phase 3 | Status: COMPLETED